By Chaitanya | BBA Finance Graduate & 6+ Years of Experience in Stock market & Finance
India Glycols Ltd (IGL), a well-known Indian diversified company, has been making headlines with its significant strategic announcements. The company has recently revealed a 1:2 stock split and a substantial expansion in its alcoholic beverage portfolio, aiming to boost market presence and shareholder value. These moves come as the company’s stock, symbolised as INDIAGLYCO, continues to show impressive growth, attracting considerable investor attention. Market observers, including leading financial news outlets, have noted these developments as crucial for IGL’s future trajectory.
Expanding Horizons in the Premium Spirits Segment
IGL is set to make a bigger splash in the Indian alcoholic beverages market. The company has extended its long-standing partnership with Amrut Distilleries Private Limited, securing brand licensing rights. This pivotal agreement allows India Glycols to manufacture, distribute, and sell popular premium Amrut brands, including MaQintosh Whisky, Old Port Rum, Bejoice XO Brandy, and MaQintosh White Label Whisky.
The primary focus of this expansion is the premium whisky segment, typically featuring bottles priced above ₹1,000 for 750 ml, particularly in North India. IGL plans to aggressively expand its market reach into new territories like Kerala and the paramilitary markets, signalling a robust push for growth.
Furthermore, a significant strategic initiative involves the proposed demerger of IGL’s spirits business, with plans to list it as a separate entity on the stock exchange. This move is expected to unlock value for shareholders and provide greater focus for the spirits division. Currently, around 25% of IGL’s total revenue comes from its Indian Made Foreign Liquor (IMFL) business. The company aims to capture a double-digit market share in the relevant premium whisky segment across North India within the next couple of years, according to statements from company officials.
India Glycols Stock Split: What Investors Need to Know
To enhance liquidity and make its shares more accessible to a broader investor base, including retail participants, India Glycols has declared a 1:2 stock split. This means that each equity share with a face value of ₹10 will be divided into two equity shares, each having a face value of ₹5. This decision, as highlighted in recent financial reports, reflects the company’s commitment to improving share affordability.
The company has set a specific timeline for this corporate action:
| Company | India Glycols Limited (INDIAGLYCO) |
|---|---|
| Split Ratio | 1:2 (₹10 face value split into two shares of ₹5 each) |
| Record Date | August 12, 2025 |
| Ex-Date | August 12, 2025 |
| Eligibility | Shareholders holding on or before cum-date (August 11, 2025) |
| Credit Timeline | Within 2-3 trading days from record date |
For investors, the impact of a stock split is straightforward: while the number of shares you own doubles, the price per share reduces proportionally, ensuring your total investment value remains the same. For instance, if an investor held 100 shares valued at ₹1,770 each before the split (totaling ₹177,000), they would hold 200 shares at ₹885 each after the split, with the total value still at ₹177,000. New shares are expected to be credited to eligible shareholders within two to three trading days from the record date.
Impressive Stock Performance Fueling Growth
The announcement of the India Glycols stock split follows a period of robust performance for its shares. The stock has surged by a remarkable 72% from its 52-week low of ₹1,005 per share. Over the past five years, IGL has delivered exceptional returns of approximately 530%, significantly rewarding long-term investors. This consistent growth, often reported by financial media outlets monitoring the Indian market, underscores the company’s strong fundamentals and positive market sentiment.
About India Glycols Ltd
Established in 1988, India Glycols Ltd is a pioneering company recognised for its focus on green technology-based chemicals and a highly diversified product portfolio. Beyond spirits, its operations span various segments, including natural gums, industrial gases, sugar, and nutraceuticals. Its Bio-based Specialties and Performance Chemicals division forms the backbone of its business, contributing 64% of its revenue. This segment includes crucial products like Bio-based Glycols (MEG, DEG, TEG, Heavy Glycols), Glycol Ethers & Acetates, Ethylene Oxide Derivatives, Bio Fuel, Bio Polymers, Industrial Gases, Amines & Plasticisers. IGL’s products serve a wide array of industries, from FMCG and food & beverage to health, coatings, and automotive sectors.
The Road Ahead for India Glycols
With a clear strategy to expand its premium spirits business and a proactive step to enhance share liquidity through the India Glycols stock split, the company appears well-positioned for continued growth. These strategic initiatives are expected to not only boost the company’s market share in key segments but also attract a wider investor base, potentially leading to further appreciation in shareholder value. Investors will keenly watch how the demerger of the spirits business unfolds and its impact on the company’s overall performance.
Disclaimer: All stock-related information, financial results, Price Targets and ratings shared on IPOC are strictly for informational and educational purposes only. The views and investment tips expressed by investment experts/broking houses/rating agencies on IPOcenter.in are their own, and not that of the website or its management None of the content published here should be considered as financial advice or a recommendation to invest. IPOC and its authors are not liable for any losses arising from decisions made based on the content of this article. Please consult a SEBI-registered financial advisor before making any investment decisions. The images used in this article are generated Images and meant for illustration purposes only.
